Accolade (ACCD) News Today → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free ACCD Stock Alerts $9.19 -0.21 (-2.23%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAccolade: Fiscal Q4 Earnings Snapshotsfgate.com - April 25 at 9:06 PMACCD Stock Earnings: Accolade Misses EPS, Beats Revenue for Q4 2024msn.com - April 25 at 9:06 PMAccolade Inc (ACCD) Surpasses Revenue Expectations and Narrows Losses in Fiscal Q4 and Full ...finance.yahoo.com - April 25 at 9:06 PMAccolade Announces Results for Fiscal Fourth Quarter and Full Year 2024globenewswire.com - April 25 at 4:03 PMStifel cuts Accolade stock price target to $13, maintains buy ratinginvesting.com - April 24 at 2:38 PMAccolade, Inc. (ACCD)finance.yahoo.com - April 23 at 10:14 AMAccolade (NASDAQ:ACCD) Price Target Cut to $13.00 by Analysts at Stifel Nicolausamericanbankingnews.com - April 23 at 3:18 AMAlphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Mondaybenzinga.com - April 22 at 9:25 AMAccolade CEO Rajeev Singh sells $3.1k in stockinvesting.com - April 21 at 12:27 AMAccolade Inc Ordinary Sharesmorningstar.com - April 18 at 10:48 PMAccolade (ACCD) Scheduled to Post Quarterly Earnings on Thursdayamericanbankingnews.com - April 18 at 1:58 AMAccolade (NASDAQ:ACCD) Shares Up 2.9%marketbeat.com - April 17 at 2:16 PMAccolade CFO exercises options, sells shares for tax obligationsuk.investing.com - April 14 at 7:01 PMAccolade, Inc. (NASDAQ:ACCD) Stock Holdings Boosted by Vanguard Group Inc.marketbeat.com - April 8 at 4:09 AMAccolade: Staying Bullish On Favorable Developmentsseekingalpha.com - April 5 at 9:28 AMAccolade (NASDAQ:ACCD) Shares Down 2.8% marketbeat.com - April 3 at 3:27 PMAccolade to Announce Fiscal Fourth Quarter 2024 Financial Resultsfinance.yahoo.com - April 3 at 10:55 AMRecent uptick might appease Accolade, Inc. (NASDAQ:ACCD) institutional owners after losing 24% over the past yearfinance.yahoo.com - April 1 at 10:31 AMARK Investment Management LLC Raises Stock Position in Accolade, Inc. (NASDAQ:ACCD)marketbeat.com - March 28 at 6:39 AMAccolade (NASDAQ:ACCD) Stock Price Up 4%marketbeat.com - March 26 at 12:38 PMAccolade Wins 2024 Artificial Intelligence Excellence Awardprnewswire.com - March 20 at 9:00 AMNational Accolade Bestowed on Arkansas-Based Provider: ‘Best Rural High Speeds'businesswire.com - March 19 at 3:00 PMAccolade Promotes Kelsi McDonald Harris to Chief People Officerprnewswire.com - March 19 at 9:00 AMACCD Apr 2024 10.000 callfinance.yahoo.com - March 17 at 1:21 AMACCD Apr 2024 12.500 callfinance.yahoo.com - March 16 at 10:00 AMAccolade (NASDAQ:ACCD) Shares Down 4.4% marketbeat.com - March 15 at 2:18 PMAccolade Inc.barrons.com - March 15 at 9:18 AMChesapeake Bank receives AARP accolade for combatting financial exploitationproactiveinvestors.com - March 12 at 8:56 AMLeerink Partnrs Weighs in on Accolade, Inc.'s FY2024 Earnings (NASDAQ:ACCD)marketbeat.com - March 6 at 8:13 AMAccolade, Inc. (NASDAQ:ACCD) to Post FY2024 Earnings of ($1.36) Per Share, Leerink Partnrs Forecastsmarketbeat.com - February 29 at 8:53 AMAnalysts Offer Predictions for Accolade, Inc.'s Q1 2025 Earnings (NASDAQ:ACCD)marketbeat.com - February 28 at 9:56 AMAccolade To Present at Upcoming Investor Conferencesglobenewswire.com - February 28 at 8:00 AMAccolade Welcomes Brightline to Trusted Partner Ecosystemprnewswire.com - February 27 at 9:00 AMNumerai GP LLC Has $198,000 Stock Holdings in Accolade, Inc. (NASDAQ:ACCD)marketbeat.com - February 27 at 8:38 AMLeerink Partners Initiates Coverage of Accolade (ACCD) with Outperform Recommendationmsn.com - February 26 at 9:09 PMAccolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)markets.businessinsider.com - February 26 at 4:08 PMAccolade (NASDAQ:ACCD) Shares Gap Up to $10.22marketbeat.com - February 26 at 11:27 AMSVB Leerink Begins Coverage on Accolade (NASDAQ:ACCD)marketbeat.com - February 26 at 7:06 AMDeutsche Bank AG Lowers Position in Accolade, Inc. (NASDAQ:ACCD)marketbeat.com - February 26 at 4:52 AMAlabama's Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providersinvestorplace.com - February 23 at 2:14 PMAccolade Stock (NASDAQ:ACCD), Short Interest Reportbenzinga.com - February 22 at 10:29 PMHighTower Advisors LLC Purchases Shares of 222,527 Accolade, Inc. (NASDAQ:ACCD)marketbeat.com - February 22 at 4:40 AMClariVest Asset Management LLC Makes New $912,000 Investment in Accolade, Inc. (NASDAQ:ACCD)marketbeat.com - February 20 at 10:16 AMAccolade, Inc. (NASDAQ:ACCD) Receives Average Rating of "Moderate Buy" from Brokeragesmarketbeat.com - February 17 at 1:53 AMAccolade (NASDAQ:ACCD) Stock Price Down 4.1%marketbeat.com - February 16 at 12:42 PMAccolade, Inc. (NASDAQ:ACCD) Sees Significant Decrease in Short Interestmarketbeat.com - February 13 at 5:02 AMPLTR Mar 2024 12.000 putca.finance.yahoo.com - February 7 at 11:49 PMAccolade (NASDAQ:ACCD) Shares Up 9.2%marketbeat.com - February 6 at 2:01 PMDoes Accolade (ACCD) Have the Potential to Rally 25.58% as Wall Street Analysts Expect?finance.yahoo.com - February 5 at 12:42 PMAccolade Welcomes Kindbody to Trusted Partner Ecosystemfinance.yahoo.com - January 23 at 10:20 AM Get Accolade News Delivered to You Automatically Sign up to receive the latest news and ratings for ACCD and its competitors with MarketBeat's FREE daily newsletter. Email Address The World's First "$20 Trillion Drug?" (Ad)One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%! Get the name of the stock here >>> ACCD Media Mentions By Week ACCD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACCD News Sentiment▼-0.170.38▲Average Business Services News Sentiment ACCD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACCD Articles This Week▼163▲ACCD Articles Average Week Get Accolade News Delivered to You Automatically Sign up to receive the latest news and ratings for ACCD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMXI News VVI News CNDT News PSFE News LQDT News RPAY News RGP News SEZL News PRTH News PAYS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACCD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsI’m afraid WWIII is a very real possibility Porter & CompanyThe AI stock to buy right nowStockEarningsThe Next Nvidia?InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accolade, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
